Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsBrian Mueller - ...
REGENXBIO Inc. today announced new positive interim data from the Phase I/II AFFINITY DUCHENNE trial of RGX-202, a potential best-in-class gene therapy for Duchenne muscular dystrophy. Trial ...
Did you take part in the race this year? Tell us all about your 2007 Great North Run experiences here. If you were a runner in the 2007 Great North Run and want to share your experiences with others, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results